Tos-Gly-OH; N-Tosylglycine; N-[(4-methylphenyl)sulfonyl]glycine; 2-(4-Methylphenylsulfonamido)acetic acid; N-(p-Toluenesulfonyl)glycine; N-4-Tosylglycine; 2-[(4-methylphenyl)sulfonylamino]acetic acid; Glycine, N-[(4-methylphenyl)sulfonyl]-; MFCD00045898; N-(toluene-4-sulfonyl)-glycine; (Toluene-4-sulfonylamino)-acetic acid; CHEMBL287486; Glycine, N-((4-methylphenyl)sulfonyl)-; Tosylglycin; tosyl-glycine; NSC25821; NSC 25821; PubChem23322; N-p-Tosylglycine, 97%; ACMC-2098yp; Oprea1_169137; CBDivE_003168; KSC909C7T; SCHEMBL760439; Glycine, N-p-toluenesulfonyl-; n-(toluene-4-sulfonyl)glycine; N-p-toluenesulfonyl-dl-glycine; CTK8A9179; KS-00000MQJ; ZINC78012; DTXSID00148355; HMS1607N08; ACT00053; ALBB-020390; N-[(4-Methylphenyl)sulfonyl]glycne; ANW-15887; BBL022967; BDBM50016567; NSC-25821; STL087629; AKOS001060050; AM81796; MCULE-2817141186; VZ33397; NCGC00325861-01; 2-(4-methylbenzenesulfonamido)acetic acid; AK-45589; BR-45589; DS-13625; SY033142; AB0019868; DB-040805; BB 0219377; CS-0046764; EU-0000679; FT-0633313; ST50072294; V0423; 2-[(4-methylphenyl)sulfonylamino]ethanoic acid; K-0593; ([(4-Methylphenyl)sulfonyl]amino)acetic acid #; 2-{[(4-methylphenyl)sulfonyl]amino}acetic acid; AB00275149-04; A801797; SR-01000393622; J-002047; J-523301; SR-01000393622-1; Z45658546; F0020-0600